FindTrial
Sign In

Study on the role of Next generation sequencing in the diagnosis of fever diseases

Study on the role of Next generation sequencing in the diagnosis of fever diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016611
Enrollment
Unknown
Registered
2018-06-12
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fever Disease

Interventions

Gold Standard:bacterial culture/Polymerase Chain Reaction
Index test:Next&#32
generation&#32
sequencing

Sponsors

The First Affiliated Hospital of Zhejiang University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Body temperature exceeds 38 degrees for 7 days; 2. No effective anti-infective therapy for more than 5 days after experience or according to bacterial culture results. Aged 18 years or older.

Exclusion criteria

Exclusion criteria: 1. The pathogen of infection has been identified by culture or PCR before admission; 2. Non-infectious diseases have been identified through pathology and other diagnostic methods before admission

Design outcomes

Primary

MeasureTime frame
NGS;bacterial culture;PCR;—

Secondary

MeasureTime frame
prognosis;DoseIntensity;blood routine examination;Inflammatory;temperature;—

Countries

China

Contacts

Public ContactXueling FANG

The First Affiliated Hospital of Zhejiang University Medical College

13588867114@163.com+86 13588867114

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026